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Abstract
Purpose:  Colorectal cancer (CRC) screening has been shown to decrease CRC mortality.
Organised mass screening programs are being implemented in France. Its perception in the general
population and by general practitioners is not well known.
Methods: Two nationwide observational telephone surveys were conducted in early 2005. First
among a representative sample of subjects living in France and aged between 50 and 74 years that
covered both geographical departments with and without implemented screening services. Second
among General Practionners (Gps). Descriptive and multiple logistic regression was carried out.
Results: Twenty-five percent of the persons(N = 1509) reported having undergone at least one
CRC screening, 18% of the 600 interviewed GPs reported recommending a screening test for CRC
systematically to their patients aged 50–74 years. The odds ratio (OR) of having undergone a
screening test using FOBT was 3.91 (95% CI: 2.49–6.16) for those living in organised departments
(referent group living in departments without organised screening), almost twice as high as impact
educational level (OR = 2.03; 95% CI: 1.19–3.47).
Conclusion: CRC screening is improved in geographical departments where it is organised by
health authorities. In France, an organised screening programs decrease inequalities for CRC
screening.
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Background
Evidence of the efficacy of screening for colorectal cancer
(CRC), in terms of both reduced mortality and reduced
incidence through removal of adenomatous polyps, led
both the U.S. Preventive Services Task Force [1] and the
Advisory Committee on Cancer Prevention in the Euro-
pean Union [2] to recommend mass screening. Colorectal
cancer organised screening is increasing at different
regional and national levels [3]. In 1998 the French
National Consensus Conference on Colorectal Cancer
distinguished three levels of risk (moderate, high or very
high) and advocated the use of Hemoccult II for mass
screening of subjects with moderate risk [4]. Based upon
academic initiatives, early studies have been carried out in
3 French departments since 1998 or earlier [5]. Later on,
the French national cancer plan focused on screening
interventions, including CRC and, from 2003 onwards,
regional organised screening programs were set up within
a national plan with the objective of nationwide coverage
by the end of 2007 [6]. In these programs, biennial faecal
occult blood test (FOBT) is first provided by Gps, free on
charge, to all subjects aged 50 to 74 years. Over a 4 to 6
month period, the test is mailed to non participants with
eventualy a reminder letter. The ongoing progressive
implementation of colorectal cancer screening in France
affords the unique opportunity to look at differences in
compliance, knowledge of population and physicians
attitudes between areas with or without organised screen-
ing programs.
The EDIFICE nationwide survey was carried out in early
2005 to provide a snapshot of cancer screening proce-
dures in France in 4 selected cancer indications, including
CRC. Results of this survey for CRC screening are pre-
sented hereunder.
Methods
Framework
France administration (including Health administration)
is divided into 20 "Regions" (Equivalent to Provinces in
Canada or Landers in Germany but with less empower-
ment than states in the USA) and 95 "Departments". The
mean number of inhabitants is 3,1 million for Regions
and 650 000 for Departments.
When organised, disease screening is currently carried out
at the departmental level after decision at the national
level. Once a decision is made about which services to
offer and to whom (decision and funding at the national
level), the local health administration submit to the
Health Ministry an authorization to start the program,
once fulfil all the specifications described by the Ministry.
For colorectal cancer the specifications mainly are the fol-
lowing: Training of GP, an information letter to every
affiliated to the National Health Insurance System
(almost every person living in France) age 50–74y, no
more than one center to analyse FOBT by department, the
utilization of Hemoccult, description of criteria for not
undergone FOBT (among which familial history of Color-
ectal cancer...).
Therefore there is a national way to organised screening,
but local differences about when the program started.
General Population survey
A nationwide observational survey (opinion poll) was
carried out by telephone from January 18t to February 2,
2005 among a representative sample of subjects living in
France and aged 40–74 years. Representativeness of the
survey sample for gender, age, profession and double
stratification by geographical area and community size as
compared to the French general population was ensured
by the use of the method of quotas [7], based on the sta-
tistics of the French Employment Survey conducted in
2002 by the French National Institute for Statistics and
Economical Studies (INSEE). The 170-item survey ques-
tionnaire was administered by trained and independent
interviewers of TNS-Healthcare SOFRES using the Com-
puter-Assisted Telephone Interview (CATI) technique.
Telephone interviews lasted 25 minutes on average. On
account of the size of the questionnaire, questions con-
cerning four cancers studied (breast, colorectal, prostate
and lung cancer) were rotated during the successive tele-
phone interviews. The survey questionnaire collected
information about subjects' socio-demographic character-
istics (gender, age, residence area, community size), atti-
tude and behaviour regarding cancer screening (in general
and for the four organs concerned), actual experience of
cancer screening, and attitude as regards personal health
(self-medication, perceptions on vaccination, medical
consultation during the past year, tobacco and alcohol
consumption). The questionnaire distinguished tests per-
formed for screening purpose and those performed fol-
lowing symptoms. A main sample of 1 509 subjects aged
between 40 and 74 years was interviewed. An additional
sample of 100 subjects aged between 50 and 74 years (rec-
ommended age interval for the screening of CRC) was
also interviewed in order to obtain a representative
number of subjects living in the 22 French departments
involved in organised CRC screening programs. Compu-
terised weighting [8] of the whole sample of 1 609 sub-
jects allowed for compensation of under-representation of
the additional sample in the whole sample (adjustment to
the proportion of all subjects living in the 22 departments
involved in organised CRC screening programs). Subjects
with a personal history of cancer (N = 105) were excluded
from analysis because actual experience of cancer might
affect cancer screening perceptions. Therefore, the whole
subject sample analysed was comprised of 1 504 individ-
uals aged between 40 and 74 years, among whom 970BMC Cancer 2008, 8:104 http://www.biomedcentral.com/1471-2407/8/104
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subjects of both genders aged 50–74 years were inter-
viewed for CRC screening. Precision of results for this
sample was ± 3.2% with 95% confidence interval (CI).
Survey among General Practitioners
The survey (opinion poll) was carried out by telephone
from January 31 to February 18, 2005 among a represent-
ative sample of French general practitioners (GPs). Repre-
sentativeness of the survey sample for age and region of
residence (five regions) as compared to the national pop-
ulation of GPs was ensured by the use of the method of
quotas [7]. The 45-item survey questionnaire collected
information about GPs' socio-demographic characteris-
tics (gender, age, department of France) and their medical
practice regarding screening of cancer (breast, colorectal,
prostate, and lung cancer), especially perceptions on
screening methods, level of screening counselling, screen-
ing tests recommended, perceived obstacles to screening,
and persons'expectations about cancer screening accord-
ing to GPs. Six hundred GPs were interviewed in order to
obtain a sufficient number of GPs practicing in the depart-
ments of France involved in planned screening of colorec-
tal cancer (N = 178; 30%).
Statistical analysis
The departments were divided into two categories accord-
ing to the existence or absence of an organised colorectal
cancer screening program. Among the "organised" depart-
ments (N = 22), two groups were defined according to the
timing of the initial program implementation:
- more than 18 months ago: twelve "first-wave" depart-
ments (Côte-d'Or, Ille-et-Vilaine, Saône-et-Loire
Charente, Indre-et-Loire, Calvados, Haut-Rhin, Hérault,
Isère, Seine Saint Denis, Bouches-du-Rhône, Nord) which
started in 2003 or earlier;
- about 12 months ago: ten "second wave" departments
(Allier, Ardennes, Essonne, Finistère, Marne, Mayenne,
Moselle, Orne, Puy-de-Dôme, Pyrénées-Orientales)
which started in 2004.
Data analysis was essentially descriptive. Quantitative
data were described by the means and standard deviations
(SD) and categorical data by the numbers in each category
and corresponding percentages. Statistical comparisons
were carried out by the Student's t test for quantitative
data, and by the Z test and the Chi-square test for the com-
parison of percentages and numbers, respectively, in the
case of categorical data. Differences were considered sta-
tistically significant when the probability value was less
than 0.05 (bilateral test). Multivariate logistic regression
analyses were expressed in terms of odd ratio (OR) and
95% CI and performed using the SAS® software, version
8.2 (proc FREQ and proc LOGISTIC procedures).
Results
At the time of initiation of the EDIFICE Survey, organised
screening programs proposed FOBT in 22 of 95 metropol-
itan departments, corresponding to an estimated
18,230,000 inhabitants in 2003 or 30% of the national
population (or 4,650,000 subjects aged 50–74 years, cor-
responding also to 30% of the national population in the
same age range).
Subjects' characteristics
The median age of the 970 interviewed subjects was 61
years, 52% were female, 42% lived in towns with >
100,000 inhabitants, 28% lived alone and 89% had vis-
ited a physician within the last 12 months.
Screening tests (Table 1, 2 and 3)
Two hundred and forty subjects (25%) reported having
undergone at least one screening test for CRC. Among
them, 76% declared having undergone the test based on
individual initiative compared to 24% within an organ-
ised screening program. The majority (53%) declared hav-
ing undergone endoscopy alone (without distinction
available between colonoscopy and sigmoidoscopy),
while 46% report having undergone FOBT ± endoscopy.
This trend was reversed in the 22 pilot departments (FOBT
65%; endoscopy alone 35%). Subjects in extreme age cat-
egories (50–54 and 70–74 years) declared having under-
gone significantly less screening tests than other categories
(Table 1). Subjects living in the 22 departments with
organised screening programs reported having undergone
significantly more screening tests than others (OR = 1.99;
95% CI: 1.47–2.69; p < 0.01), including 52% of them
within screening programs (Table 1). In these depart-
ments, the percentage of subjects declaring having under-
gone a screening test significantly increased with the age
of the local program, from 26% in the most recently
implanted, to 37% in the first-wave departments (p =
0.03, OR = 1.76 – IC 95% 1.06–2.93).
Factors influencing screening test performance
Characteristics of screened and unscreened subjects were
compared. In the univariate analysis (Table 2), signifi-
cantly more unscreened subjects lived alone and lived
outside the 22 departments with organised screening. Sig-
nificantly fewer of them had visited a gastroenterologist
within the past 12 months, were concerned/motivated by
screening, were afraid of CRC and had cancer or CRC cases
among their relatives or friends. Lastly, unscreened sub-
jects had significantly lower incomes than screened sub-
jects. After multivariate logistic regression analysis, eight
independent variables influenced screening (six positively
and two negatively), irrespective of the test used (FOBT
and/or endoscopy) (Table 3). The strongest predictive var-
iable (OR: 5.55; 95% CI: 3.02–10.19) was to have visited
a gastroenterologist within the last 12 months. However,BMC Cancer 2008, 8:104 http://www.biomedcentral.com/1471-2407/8/104
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when only screening with FOBT is taken into account,
only four positive variables remained correlated with
screening. Living in one of the 22 departments with
organised screening programs was the strongest predictive
variable, followed by motivation/concern for CRC screen-
ing and educational level, while the influence of gastroen-
terologists disappeared (Table 3).
Among the subjects declaring having been screened in the
22 pilot departments, 52% did so within an organised
program and 46% based upon individual initiative.
Almost all subjects (93%) who participated in mass
screening programs underwent FOBT, compared to 34%
of subjects screened based upon individual initiative (p <
0.01), whereas only 26% underwent endoscopy, com-
pared to 74% (p < 0.01), respectively. Sixty-four percent of
subjects who participated in mass screening programs
were invited to do so through a mailing campaign from
the French Health Care System ("Social Security"). Sub-
jects in screening programs were significantly older at the
time of their first screening (57.8 versus 52.3 years; p <
0.01).
Table 1: Declaration of having undergone at least one colorectal cancer screening test according to subjects characteristics.
% of subjects declaring screening test P value
ALL (n = 970) 25%
Gender
• Male (n = 462) 24%
• Female (n = 507) 26% 0.47
Age (years)
• 50–54 (n = 213) 19%
• 55–59 (n = 241) 30%
• 60–64 (n = 180) 28%
• 65–69 (n = 179) 27%
• 70–74 (n = 157) 18% 0.01
French department of residence
• With organised screening (n = 329) 34%1
• Without organised screening (n = 641) 20% <0.01
Age of organised program
• More than 18 months ago ("first-wave") (n = 220) 37%2
• About 12 months ago ("second-wave") (n = 109) 26%3 0.03
1including 17% of screening tests performed within organised programs
2 including221%; 410%, respectively, of screening tests performed within organised programs (p = 0.04)
Table 3: Variables increasing the probability of being screened. Multivariate analyses
Variable Odd ratio (95% CI)
Regardless of screening procedure (either FOBT or endoscopy)
Having visited a gastroenterologist within the last 12 years 5.55 (3.02–10.19)
Living in the 22 departments with organised screening programs 3.89 (2.52–5.98)
Being concerned by CRC screening 2.60 (1.43–4.71)
Being motivated by CRC screening 2.26 (1.27–4.02)
Being confident in screening efficacy 1.98 (1.15–3.40)
Having high educational level (College or higher) 1.74 (1.05–2.90)
Being afraid by results of screening tests 0.47 (0.29–0.77)
Living in Paris or suburb 0.37 (0.15–0.92)
With FOBT ± endoscopy
Living in the 22 departments with organised screening programs 3.91 (2.49–6.16)
Being concerned by CRC screening 3.17 (1.75–5.72)
Having high educational level (College or higher) 2.03 (1.19–3.47)
Being motivated by CRC screening 2.02 (1.13–3.62)
Being afraid by results of screening tests 0.56 (0.34–0.93)
Being 50–54 year old 0.40 (0.19–0.86)BMC Cancer 2008, 8:104 http://www.biomedcentral.com/1471-2407/8/104
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Table 2: Variables increasing the probability of being screened. Univariate analyses
Model 1 Model 2
Regardless of screening procedure£ Not screened With FOBT + endoscopy Not screened
N = 132 N = 838 N = 112 N = 730
Region:
Paris and around 11%* 18% 8%* 19%
West 30% 23% 34%* 23%
South West 5%** 12% 6%** 13%
Size of city :
Paris or suburb 9%* 16% 7%** 17%
Age :
Being 50–54 year old 18% 22% 12%** 24%
Being 55–59 year old 32% 24% 33%* 23%
Being 70–74 year old 11%* 17% 12% 18%
Visited Physicians :
Having visited a doctor within the last 12 years 95%** 88% 95%** 88%
Having visited a g-e within the last 12 years 22%** 5% 8% 5%
History of cancer :
Cancer(s) in family or close circle 79%** 66% 77%* 66%
Colorectal Cancer(s) in family or close circle 14%* 7% 8% 5%
Other general believes :
I make decisions easily 66%* 55% 63% 55%
Concerning my health, I have to face up to my 
responsibilities
89%* 82% 88% 83%
Opinions/fears about cancer :
I think having more cancer risks than most of the 
people
28% 24% 17%* 24%
Being afraid of colorectal cancer 64%* 51% 60%* 49%
Being afraid of screening tests 22%** 39% 24%** 41%
Giving the adequate definition of screening 63% 55% 65%* 55%
Being confident in screening efficacy 83%** 65% 80%** 63%
Quoting FOBT as a screening test 44%** 15% 57%** 14%
Quoting endoscopy as a screening test 67%** 46% 47% 43%
Opinion about colorectal cancer :
Being motivated by CRC screening 74%** 33% 64%** 28%
Being concerned by CRC screening 77%** 39% 72%** 33%
CRC is an important process 83%** 54% 81%** 50%
In the future :
Intent to do a screening test in the future 58%* 46% 74%** 43%
-To do so in the "organised screening" 14% 9% 20%** 9%
-Do not care 34%* 21% 42%** 20%
French department of residence :
With organised colorectal cancer screening 59%** 30% 64%** 30%
£: either FOBT or endoscopy **p < 0.01 *p < 0.05
List of variables included in the models: Gender, Age, Work status, City of living's size, Educational level, Marital status. Self-medication, 
Vaccination. Anxiety about his/her health. Screening of breast cancer: screnned (follow-up or not)/never screened. Having visited a GP, a 
gastroenterologist within the last 12 years. Attitudes towards his/her health (responsibility, take care without delay, no influence, doctor's 
business). History of cancer (in general and colorectal) in his/her family/close circle. Being afraid by cancer, colorectal cancer, screening tests. Being 
confident in screening efficacy. Being concerned, motivated by CRC screening, CRC is an important process. Year of instauration of breast cancer 
screening programThe existence of an organised colorectal cancer screening programBMC Cancer 2008, 8:104 http://www.biomedcentral.com/1471-2407/8/104
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Perception of CRC screening by population
Fifty-six percent of interviewed subjects gave an adequate
definition of cancer screening and 88% knew that screen-
ing increases the likelihood of CRC cure. In the 22 pilot
departments, 86% of interviewed subjects felt the invita-
tion by mail was motivating and only 6% found it worry-
ing. Individuals who did not undergo screening tests were
invited to state the reason from a limited pre-established
list. Few differences appeared between the two categories
of departments. "Feeling of not being concerned" was
lower, although not significantly, in organised depart-
ments (33% versus 38% of subjects; OR = 0.83; 95% CI:
0.59–1.16);"having no symptoms" was also not signifi-
cantly lower in organised departments (17% versus 21%;
OR = 0.76; 95% CI: 0.50–1.14) and "fear of the test and/
or its results" was higher in organised departments (11%
versus 6%; OR = 1.97; 95% CI: 1.11–3.49).
Screening attitudes and perceptions of GPs
Eighteen percent of the 600 interviewed GPs reported rec-
ommending a screening test for CRC systematically to
their patients aged 50–74 years, while others declared to
"often" (48%), "seldom" (28%), or "never" (6%) recom-
mend doing so. The proportion of GPs who reported sys-
tematically recommending a test was higher in the 22
pilot departments than in other departments (29% versus
13%; p < 0.01) and increased, but not significantly, with
the age of the local program (26% in the "second-wave"
departments, and 30% in the first wave depârtments; p =
NS, OR = 1.20 – IC95% 0.58–2.51). The main reasons
given by GPs for not systematically recommending screen-
ing tests (Table 4) were the belief that screening should be
restricted to subjects at risk (28%) and the feeling that
they were not associated to the general program (19%).
On the contrary, GPs considered that patients' reluctance
to perform screening tests is related to fear of results
(16%), feeling of not being concerned (11%), non-rec-
ommendation by GP (9%) or lack of information (8%).
Discussion
The EDIFICE nationwide survey was carried out to pro-
vide a snapshot of cancer screening procedures in France
in 4 selected cancer indications, including CRC. This sur-
vey relies on self-reported data and does not report the
actual incidence of screening tests for CRC. Though the
questionnaire was discriminative for true screening, it is
likely that some of the reported "screening tests" were
actually diagnostic tests following discrete symptoms,
especially for tests performed based on physician's pre-
scription. Self-report accuracy of screening tests may be
test-dependent and FOBT has been shown to be under-
reported [9] but also over-reported [10]. Nevertheless,
self-reported screening behaviour is generally fairly accu-
rate [11,12], and many publications rely upon this. How-
ever, this survey does have limitations inherent to the
design (cross-sectional) or a limited generalizability due
to the economic and organisational French background.
The first observation of this survey is the low rate (25%)
of reported screening for CRC in France in the target pop-
ulation aged 50–74 years, in contrast with a high level of
scientific evidence and official recommendation [1,2].
This low rate is close to [13,14] rates observed in other
Western countries, but significantly lower than the figures
in recent publications. For instance in 2004, the rate for
US adults above 50 y who reproted receiving either a
FOBT within one year or an endoscopic examination
within 10 years is 57.1% [15].
In contrast to other developed countries [13], the financ-
ing of screening tests, whether they are performed individ-
ually or within an organised program, is not an issue,
since they are all paid for by the French Health Care Sys-
tem.
The second point is the influence of locally organised
screening programs on screening attitudes of both popu-
lation and GPs. The rate of subjects reporting having been
screened (either individually or through screening pro-
Table 4: Reasons given by the Gps for not systematically give the recommendation for screening. N = 492
Reasons Rate
Recommendation to âtients at risk only 28%
Not enough involved in the process by official institutions 19%
The ration costs/benefit is high 9%
The difference between costs & benefit is low 9%
Neglect 8%
The National Health Insurance is in charge of this recommendation 5%
Patient's choice 4%
Difficulty of the realisation – The screening tests are uneasy 4%
Screening tests are not very efficient 3%
It is gastroenterologist's role <1%
Other reasons (others priorities...) 4%BMC Cancer 2008, 8:104 http://www.biomedcentral.com/1471-2407/8/104
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grams), the rate of GPs systematically recommending
CRC screening, the proportion of subjects screened under-
going FOBT, compared to endoscopy, as well as that of
subjects having performed a test within the last two years,
were all increased in departments where an organised
screening program exists. Organised cancer screening is
indeed assumed to be more effective than opportunistic
screening [16]. Furthermore, it has been shown to
improve guideline compliance, especially with regard to
the adequacy of examinations that should follow positive
FOBT [16-18], and therefore are likely to protect subjects
from the risk of poor-quality screening practices and to
guarantee screening cost-effectiveness [16].
The most important finding of our survey is that the exist-
ence of an organised local screening program is the
strongest independent predictive factor of performing a
screening test in the logistic regression analysis (Table 3).
When only FOBT is considered, almost 4 times subjects
living in the 22 pilot departments reported undergoing
screening tests than those living in other departments and
it is anticipated that this difference will grow over time
with program implantation. Furthermore, living in a pilot
department is almost twice as predictive as educational
level (Table 3). This finding suggests that the implementa-
tion of organised screening programs minimizes inequal-
ity for CRC screening. When either FOBT or endoscopy are
considered, the strongest predictive factor is having con-
sulted a gastroenterologist within the last 12 months. This
should be put into perspective with the role of endoscopy
in individually-based screening procedures. The fact that
having consulted a gastroenterologist is no longer an asso-
ciated factor when considering FOBT and endoscopy min-
imize the risk of transposition of cause and effect (visits
prompted by FOBT).
Within departments where organised programs are imple-
mented the declaration rate of screening tests (37 versus
26%), the reported rate of participation in the local pro-
gram (21 versus 10%) and the reported systematic recom-
mendation by GPs of performing screening tests (30
versus 26%) were higher in departments in which the
local program was first implanted than in those in which
it was set up recently. These correlations are likely to be
explained by the educational role of organised programs
and solicitation of population and physicians. The fact
that a decreasing rate of subjects wrongly assume that hav-
ing no symptoms is a reason for not performing a screen-
ing test, supports this assumption. In a US survey, "lack of
awareness" and "not recommended by a doctor" were the
most common barriers to CRC screening and similarly are
decreasing with time [19]. Moreover, the participation
rate in screening in the "scout" departments is close to the
objective of 50% participation as set in the French Cancer
Plan established by the French Health Ministry, and may
be the maximum achievable rate with such programs.
Nevertheless, these "scout" departments, in which mass
screening was initiated based on academic initiative, may
be more highly implicated in screening and cannot neces-
sarily be extrapolated to other departments according to
national directives.
The role of GPs is important for individual screening prac-
tices [19] particurlarly for long term compliance [20]. In
France in 2005, only 18% of them systematically recom-
mended CRC screening tests and an additional 48%
"often" recommended them. This compares with 59% of
GPs recommending tests in a Canadian survey [21]. Sur-
prisingly, the level of knowledge about CRC screening of
the general population and GPs seems correlated and sim-
ilarly influenced by organised local programs. Other yet
undetermined disease- or test-related factors may nega-
tively influence CRC screening. It has been shown, for
instance, that in a cohort of well informed women, fewer
undergo FOBT than mammography for cancer screening
[22].
Conclusion
The rate of CRC screening testing is still low in France, but
is expected to increase regularly with the nationwide
implementation of mass screening programs, which are
likely to be the main factor influencing subjects to
undergo, and GPs to systematically recommend, screen-
ing tests. Nevertheless, the rate of screening test perform-
ance in the areas with the oldest organised programs (> 6
years), about 50%, could be the highest rate achievable
with time using this kind of organisation. This could still
be considered as insufficient. Further public health
research is warranted to clarify remaining barriers and
improve the methods of informing the population and
GPs [23].
List of abbreviations
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